Fonterra inks deal with UK firm

NIKO KLOETEN
Last updated 09:27 04/07/2014

Relevant offers

Dairy

Dairy minnow looking to grow in tough times Financial survival Owl Farm's main priority for 2016-17 season Increased demand in land for honey production, dairy farm sales dry up Herd data workshop for Manawatu women Brickbats and bouquets for Fonterra reform OSPRI delays TB operation in central NI after talking to hunters Tax consequences of falling dairy livestock values West Coast minnow's dairy payout overshadows Fonterra price Fonterra board reformist Armer says no to restructure plan Analysts say Fonterra price 'where the market is'

Fonterra has signed a five-year deal to market and sell two infant formula ingredients made by British-based Dairy Crest.

The products, a prebiotic called galacto-oligosaccharide (GOS) and demineralised whey, are both used in the manufacture of infant formulas.

Fonterra will be the exclusive sales channel for the infant formula ingredients produced and will receive a commission on the sales.

Dairy Crest is entering into a newly-formed joint venture with British-based Fayrefield Foods to produce the GOS. These factories are expected to begin production next year.

Fonterra chief executive Theo Spierings said the agreement was a win-win for all the companies and each would bring their expertise to the partnership.

He said the deal aligned with Fonterra's strategy to develop a leading position in the global infant-formula market.

"Infant formula is the fastest-growing dairy category in the world," he said.

"Demand is particularly strong in Asia, where China is the leading global infant-formula market."

Fonterra was the centre of a botulism scare last year that sparked a mass recall of whey products before testing revealed it was a false alarm.

The dairy co-operative still faces legal action from French food giant Danone, which has said it lost €350 million (NZ$544m) as a result of the recall.

Ad Feedback

- Stuff

Special offers

Featured Promotions

Sponsored Content